Looks like RIBT is testing the 50 MA, so will be interesting to see what happens next. There has been a considerable amount of momentum built up over the last 6 months, but looks like the volume has been trailing off after peaking in May. You said they need to trade over 1.00 for a week or so by Sept to avoid delisting, reverse spilt, etc, so could be various factors at work driving the stock's movements.
BABYF has been a dog, but at some point there should be a dead cat bounce. A lot of 'oy veys' lately from followers of this stock lol..
SURG - no signs of buying from the index funds, but I wonder if they bought in earlier, during that May 23 high volume day (?)
AXSM - a biotech I've followed loosely for several years (see next post). No position, but should be interesting. They have a new drug for depression up for approval, but the FDA has been stonewalling for some reason. I figure the FDA is using the current lack of effective depression treatments as a key rationale for getting the various 'psych-meds', ketamine derivatives, Psilocybins, etc legalized and on the market under the guise of medical treatments. Hence the FDA is stonewalling on other more traditional depression med programs.
---
News 
Market Data 
Discover 
